Airain Ltd’s ChemoCentryx, Inc. CCXI Stock Holding History

Airain Ltd’s Portfolio CCXI Stock Details CCXI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-10,154	Closed	-$61K	–	895
2016 Q3	$61K	Buy	+10,154	New	+$48K	﹤0.01%	580

Other funds holding CCXI

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Airain Ltd's CCXI Position: Q4 2016 in Review

Airain Ltd sold out of ChemoCentryx, Inc. (CCXI) in Q4 2016, closing a stake of 10,154 shares — an estimated $61K sold.

Airain Ltd first reported a position in CCXI in Q3 2016 and held it in 1 quarter. The position peaked at $61K in Q3 2016. 89 funds tracked by Wall St. Rank hold CCXI as of Q4 2016.

Airain Ltd reported no remaining ChemoCentryx, Inc. position as of Q4 2016 after selling out during the quarter.
Airain Ltd sold 10,154 ChemoCentryx, Inc. shares in Q4 2016, an estimated $61K.
Airain Ltd first reported a position in ChemoCentryx, Inc. in Q3 2016 and held it in 1 quarter.
Airain Ltd's ChemoCentryx, Inc. position peaked at $61K in Q3 2016.
89 funds tracked by Wall St. Rank held ChemoCentryx, Inc. as of Q4 2016.

Based on Airain Ltd's 13F filing for Q4 2016, filed 10 Feb 2017.